Bellicum Pharmaceuticals Inc. buy marge
Start price
17.04.17
/
50%
€120.87
Target price
13.12.19
€162.36
Performance (%)
-93.05%
End price
13.12.19
€8.40
Summary
This prediction ended on 13.12.19 with a price of €8.40. The BUY prediction by marge for Bellicum Pharmaceuticals Inc. performed very badly with a performance of -93.05%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellicum Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by marge for this prediction
In the thread Bellicum Pharmaceuticals Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 17.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 18$ zu.Überschrift: BLCM mit beeindruckenden Daten bei Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Buy beendet
Stopped prediction by marge for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.40
13.12.19
13.12.19
€7.00
04.11.21
04.11.21
-79.17%
05.11.21
05.11.21